Background: The number of menopausal women who suffer from low level estrogen-associated type-2 diabetes has been increasing recently. The role of estrogen in metabolism of glucose depends on estrogen receptor alpha expression that is regulated by estrogen receptor alpha gene (ESR ?). PvuII and XbaI polymorphisms in the ESR ? receptor may decrease the expression of ESR ? protein and receptor activity, thereby increasing the risk of developing type 2 diabetes mellitus in menopausal women. Purpose: to determine the ESR ? polymorphism as a risk factor for type 2 diabetes mellitus (DM) in menopause women of Javanese in Indonesia Methods: Sixty five menopausal women were recruited for the study consisted of 40 women with T2DM and 25 women as control. PvuII and XbaI polymorphisms were determined by polymerase chain reacton-restriction fragment length polymorphism (PCR-RFLP). The absence of PvuII and XbaI restriction sites were indicated by "P1" and "X1" and presence by "P2" and "X2", respectively. Chai Square test were used in statistical analyisis to measure Hardy Weinberg Equilibrium (HWE) and the risk of P1/P2 and X1/X2 allele for suffering T2DM. Results: PvuII genotype was distributed as; 22.5% (P1P1), 45% (P1P2), 32.5% (P2P2) while XbaI genotype was distributed as 10 % (X1X1), 62.5% (X1X2) and 27.5% (X2X2) in diabetics respectively. There was no difference in distribution of P1 and P2 between diabetics and non diabetics but difference for X1 and X2 existed between groups. The frequency of P2 allele was 55 % while P1 allele frequency is 45% in diabetics. X2 allele frequency was 58.8% while X1 allele is 41.2%. X2 allele had an impact on the 3.6 times higher risk of getting type 2 diabetes in Javanese menopausal women (OR = 3.662, CI = 1.711 to 7.840) Conclusions: PvuII and XbaI polymorphism was found in Javanese menopause women of Indonesia in patients with type 2 diabetes mellitus. The allele frequency of P2 and X2 are 55% and 58.8% respectively. X2 allele was found as a risk factor for type 2 diabetes mellitus in Javanese menopause women of Indonesia.
Introduction
Diabetes mellitus (DM) is a systemic disease characterized by an imbalance of energy metabolism, carbohydrate, lipid and protein which is mainly caused by inadequate insulin action both relative and absolute deficiency 1 . This disease affects patient lifetime and cannot be cured without the control of plasma glucose levels in the long run. In the long term DM damage organs such as kidneys, eyes, nervous system, heart, and if not treated increase the mortality rate 2 . The prevalence of DM for all age groups worldwide It is estimated that prevalence of T2DM increase from 2.8% by the year 2000 to 4.4% by the year 2030 in the world. At the age of postmenopausal, women will get suffering DM more than men 2 . Research has been conducted in Indonesia to prove an increase in the prevalence of diabetes mellitus. For example, research conducted in Jakarta (urban area) have showed 1.7% T2DM prevalence in 1982, and 5.7% in 1993. In 2001 the prevalence of DM in sub-urban areas in Jakarta had to 12.8% 3 .
The cause of DM is combination of environmental and genetic factors impaired glucose homeostasis. In addition, insulin resistance is the main cause of metabolic syndrome characterized by hypertension, dyslipidemia, and visceral obesity which have become a worldwide health issues 4, 5 . Type 2 diabetes patients are generally older than 45 years old and have symptoms of obesity 6 . Obesity, diet, aging, lack of physical activity and urbanization is known as a major cause of increasing number of patient with DM 7 .
According to Szmuilowicz et al. (2009) many postmenopausal women will suffer type 2 DM but still little information about how changes at menopause is typically affect the incidence of DM and may also greatly affect the DM management at the time of menopause and post menopause 8 . According to Otsuki et al. (2007) that non-DM menopausal women have elevated levels of fasting blood glucose than non DM women reproductive age 9 . The risk of menopause women will increase to suffer type 2 diabetes. It is estimated associated with a decrease in estrogen levels in postmenopausal women 8, 9 .
Estrogen (E2) plays an important role in the pathogenesis of type 2 diabetes. Estrogen can prevent DM through different mechanisms, especially in reducing hyperglycemia and plasma insulin levels. Estrogen showed physiological effects primarily through estrogen receptor alpha (ESRa) and beta (b ESR) which are found in various tissues of the body. Estrogen interaction with its receptor will affect the metabolism of carbohydrates that participate in the pathogenesis of type 2 diabetes. Low estrogen increase vulnerability (susceptibility) a person to suffer type 2 diabetes through a variety of ways both men and women. Reference Several studies have shown that estrogen can inhibit the induction of IDDM or insulin dependent diabetes mellitus 7, 10, 11, 12, 26 . Estrogen can strengthen (modulate) the secretion of insulin, regulate K-ATP channel, and adjust the calcium signaling through the estrogen receptor. Estrogen can also stimulate fatty acid metabolism, suppress the production of glucose from the liver, protects pancreatic beta cells to continue to function and survive, increasing the expression of GLUT-4 and increased glucose uptake 1 .
According to Dahlman et al. (2008) 
Biochemical Analysis with physical examination
Biochemical analysis or examination carried out on venous blood samples after at least 12 hours of fasting that includes an examination of total cholesterol, triglyceride, HDL and LDL levels using a commercial kit from DiaSys Germany. In addition to biochemical examinations are also performed a physical examination including blood pressure, the height, the weight and abdominal circumference.
DNA Isolation
Isolation of DNA carried out with guanidine isothiocyanate method 15 . 
Statistical analysis
Genotype distribution of polymorphism was tested for Hardy-Weinberg equilibrium by c 2 . Also analysis of risk of allele and haplotypes increasing to suffer T2 DM were conducted by c 2 and logistic regression. A p-value less than 0.01 was considered significant. Statistical analysisi was performed with SPSS version 17.0 (SPSS Inc., Chicago, IL, USA). and THESIAS 1.3 version 16 .
Ethical Clearence
We have got ethical clearence from Bioethics Unt Faculty of Medicine Gadjah Mada University of Jogjakarta. We have done informed consent to all subjects that want to get involved in this study.
Result
Characteristics of the subjects are presented in table I. There are some variables that two groups differed significantly such as systole, diastole, height and TGA (p< 0, 01). Menopause women without DM have blood pressure higher than menopause women with DM in this research because almost all subject with DM consumed antihypertensive tablet a long with anti-diabetic treatment as consequences diabetic complication. Although the height of DM subjects is higher than non DM subjects but the BMI of both groups are normal and equal (p=0, 458). Identification of the susceptibility genes for type 2 DM thus may lead to primary prevention of the disease1. The most patients type 2 DM have affected by genetic factor contributing a partial and additive effect. The inheritance pattern is thus complex, and environmental factor play an important role in favoring or delaying the expression of the disease 11 .
Sex steroid clearly have an impact on insulin resistance risk. Recent data have revealed a surprising role of estrogen in regulating energy metobolis, which opened new insight into the role of the two estrogen receptors 23 . Therefore, estrogen receptors seem to play a role in the prevention or in the occurence of diabetes type 2 24 . ESR ? polymorphism have attracted great interest in the last few years and the PvuII and XbaI are the most extensively investigated issue 11 .
We report for the first time no significant difference in the PvuII polymorphism in Javanese population menopausal women. 26 .
The present findings are limited in the way that they were obtained from a relatively small study population and our significant findings of XbaI polymorphism may be caused by the poor statistical power. The result of our study should be considered exploratory and confirmed by additional studies, which include larger sample size and other polymorphism in estrogen receptor gene. This will help to identify the population with genetic predisposition and to protect the from exposure to enviromental risk.
This is the first Indonesian study in Javanese population to show that ESR ? polymorphism especially XbaI polymorphism is associated with increased suspectibility of Javanese menopausal women to type 2 DM. Investigation of these polymorphisms in other ethnic groups and comparing premenopausal with postmenopausal women are recommended. The molecular mechanism of type 2 diabetes pathogenesis mediated by PvuII and XbaI polymorphism should also be elucidated in experimental animals 1 .
Conclusion
In conclusion, we have able to find association between variations in the ESRa gene and risk type 2 diabetes mellitus especially for XbaI polymorphism. A-allele in the first our study become mayor allele and increased risk 4 time to suffer type 2 DM whereas PvuII polymorphism did not associate with type 2 DM in Javanese menopausal women.
